Explain how you found out that Lucy has ADA-SCID.
The Correct Answer and Explanation is :
The correct answer is: clinical evaluation, laboratory tests showing immune deficiency and enzyme activity, and genetic testing confirming the underlying genetic defect
To determine that Lucy has Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID), a systematic approach involving clinical observations, laboratory testing, and genetic analysis is typically employed.
Initially, the diagnosis may stem from Lucy presenting with symptoms of a severe immune deficiency, such as recurrent infections, failure to thrive, or unusual rashes. Given the critical role of the immune system in fighting infections, a healthcare provider may suspect a primary immunodeficiency. ADA-SCID is one of the more severe forms, characterized by the absence of functional T and B lymphocytes.
Following the initial clinical suspicion, laboratory tests are essential. A complete blood count (CBC) may reveal lymphopenia (a low lymphocyte count), which further indicates an immune deficiency. To confirm the diagnosis, a specialized blood test assessing enzyme activity would be performed. In ADA-SCID, there is a marked deficiency of the enzyme adenosine deaminase, which is crucial for the metabolism of purines. Elevated levels of toxic metabolites, such as deoxyadenosine and deoxyadenosine triphosphate, can also be measured, as they accumulate due to the lack of ADA activity.
If the enzyme activity is significantly low, genetic testing may be conducted to identify mutations in the ADA gene. This step is critical, not only for confirming the diagnosis but also for informing potential treatment options. In Lucy’s case, if both the enzyme deficiency and the genetic mutations are identified, it would provide definitive evidence of ADA-SCID.
In summary, the diagnosis of ADA-SCID in Lucy would be reached through a combination of clinical evaluation, laboratory tests showing immune deficiency and enzyme activity, and genetic testing confirming the underlying genetic defect. Early diagnosis is vital for initiating appropriate treatment, such as enzyme replacement therapy or stem cell transplantation, which can significantly improve the prognosis and quality of life for individuals with this condition.